Simplifying Global Compliance
Santarus Ulcerative Colitis Drug to Hit Shelves in March
Washington Drug Letter
The FDA has approved Santarus’ daily extended-release drug Uceris to induce remission of mild to moderate active ulcerative colitis, a form of inflammatory bowel disease.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing